Boyce Sarah — SEC Form 4 filings

SEC reporting owner CIK 1629383. 27 Form 4 filings on record with FilingPulse; latest filed 2026-06-26.

Transaction summary — filings shown

Covers all 27 filings on record, filed 2024-01-23 to 2026-06-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Avidity Biosciences, Inc. (RNAM)President and CEO, Director2123 legs · 877,801 sh · $30,724,15845
OmniAb, Inc. (OABI)Director25
Contineum Therapeutics, Inc. (CTNM)Director33
Atrium Therapeutics, Inc. (RNA)Director11

Form 4 filings — Boyce Sarah

FiledFormIssuerReported transactionsSource
2026-06-264Contineum Therapeutics, Inc. (CTNM)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2026-03-024Atrium Therapeutics, Inc. (RNA)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2026-02-274Avidity Biosciences, Inc. (RNAM)Disposition to issuer (D): 474,861 · Disposition to issuer (D): 386,015 (derivative) · Disposition to issuer (D): 300,000 (derivative) · Disposition to issuer (D): 425,000 (derivative) · Disposition to issuer (D): 400,000 (derivative) · Disposition to issuer (D): 200,000 (derivative) · +2 moreEDGAR
2026-01-234Avidity Biosciences, Inc. (RNA)Sale (S): 6,394 @ $72.45 · Sale (S): 7,993 @ $72.45EDGAR
2026-01-094Avidity Biosciences, Inc. (RNA)Sale (S): 8,576 @ $72.23EDGAR
2025-12-194Avidity Biosciences, Inc. (RNA)Grant/award (A): 31,000 @ $0 · Tax withholding (F): 15,742 @ $71.87 · Gift (G): 29,159 @ $0EDGAR
2025-09-054Avidity Biosciences, Inc. (RNA)Option exercise (M): 50,000 @ $1.24 · Sale (S): 50,000 @ $49.95 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2025-08-294Avidity Biosciences, Inc. (RNA)Option exercise (M): 25,000 @ $1.24 · Sale (S): 25,000 @ $49.39 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2025-06-264Contineum Therapeutics, Inc. (CTNM)Grant/award (A): 14,750 (derivative) @ $0EDGAR
2025-03-214Avidity Biosciences, Inc. (RNA)Sale (S): 31,540 @ $31.06EDGAR
2025-01-234Avidity Biosciences, Inc. (RNA)Sale (S): 4,738 @ $28.59 · Sale (S): 5,659 @ $28.59EDGAR
2025-01-084Avidity Biosciences, Inc. (RNA)Grant/award (A): 82,500 @ $0 · Grant/award (A): 165,000 (derivative) @ $0EDGAR
2024-12-194Avidity Biosciences, Inc. (RNA)Sale (S): 31,855 @ $32.66EDGAR
2024-09-234Avidity Biosciences, Inc. (RNA)Grant/award (A): 62,500 @ $0 · Sale (S): 32,880 @ $44.00 · Grant/award (A): 62,500 @ $0EDGAR
2024-08-074Avidity Biosciences, Inc. (RNA)Option exercise (M): 28,000 @ $1.24 · Sale (S): 28,000 @ $43.35 · Option exercise (M): 28,000 (derivative) @ $0EDGAR
2024-07-114Avidity Biosciences, Inc. (RNA)Option exercise (M): 28,000 @ $1.24 · Sale (S): 28,000 @ $39.93 · Option exercise (M): 28,000 (derivative) @ $0EDGAR
2024-06-244Contineum Therapeutics, Inc. (CTNM)Grant/award (A): 29,500 (derivative) @ $0EDGAR
2024-06-214OmniAb, Inc. (OABI)Option exercise (M): 20,000 · Option exercise (M): 20,000 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-06-204Avidity Biosciences, Inc. (RNA)Grant/award (A): 62,500 @ $0 · Sale (S): 32,074 @ $39.13 · Grant/award (A): 62,500 @ $0EDGAR
2024-06-144Avidity Biosciences, Inc. (RNA)Option exercise (M): 100,000 @ $1.24 · Sale (S): 100,000 @ $35.73 · Option exercise (M): 164,233 @ $1.24 · Sale (S): 164,233 @ $40.08 · Option exercise (M): 35,767 @ $1.24 · Sale (S): 35,767 @ $40.08 · +3 moreEDGAR
2024-06-054Avidity Biosciences, Inc. (RNA)Option exercise (M): 28,000 @ $1.24 · Sale (S): 28,000 @ $27.42 · Option exercise (M): 28,000 (derivative) @ $0EDGAR
2024-05-074Avidity Biosciences, Inc. (RNA)Option exercise (M): 28,000 @ $1.24 · Sale (S): 28,000 @ $25.54 · Option exercise (M): 28,000 (derivative) @ $0EDGAR
2024-04-234/AOmniAb, Inc. (OABI)Grant/award (A): 39,628EDGAR
2024-04-034Avidity Biosciences, Inc. (RNA)Option exercise (M): 28,000 @ $1.24 · Sale (S): 28,000 @ $26.25 · Option exercise (M): 28,000 (derivative) @ $0EDGAR
2024-03-124Avidity Biosciences, Inc. (RNA)Option exercise (M): 84,000 @ $1.24 · Sale (S): 84,000 @ $21.39 · Option exercise (M): 28,000 @ $1.24 · Sale (S): 28,000 @ $22.63 · Option exercise (M): 84,000 (derivative) @ $0 · Option exercise (M): 28,000 (derivative) @ $0EDGAR
2024-03-054Avidity Biosciences, Inc. (RNA)Option exercise (M): 84,000 @ $1.24 · Sale (S): 84,000 @ $20.13 · Option exercise (M): 84,000 (derivative) @ $0EDGAR
2024-01-234Avidity Biosciences, Inc. (RNA)Grant/award (A): 62,500 @ $0 · Sale (S): 5,092 @ $10.13 · Grant/award (A): 300,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1629383 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →